| Name | tirabrutinib |
|---|---|
| Synonyms |
tirabrutinib
MFCD28386296 8H-Purin-8-one, 6-amino-7,9-dihydro-9-[(3R)-1-(1-oxo-2-butyn-1-yl)-3-pyrrolidinyl]-7-(4-phenoxyphenyl)- UNII:LXG44NDL2T 6-Amino-9-[(3R)-1-(2-butynoyl)-3-pyrrolidinyl]-7-(4-phenoxyphenyl)-7,9-dihydro-8H-purin-8-one ONO-BKT ONO-4059 |
| Description | Tirabrutinib (ONO-4059) is a highly selective, orally bioavailable BTK inhibitor with an IC50 of 2.2 nM. |
|---|---|
| Related Catalog | |
| Target |
IC50: 2.2 nM (BTK)[1] |
| References |
| Density | 1.4±0.1 g/cm3 |
|---|---|
| Boiling Point | 672.0±65.0 °C at 760 mmHg |
| Molecular Formula | C25H22N6O3 |
| Molecular Weight | 454.481 |
| Flash Point | 360.2±34.3 °C |
| Exact Mass | 454.175354 |
| LogP | 2.31 |
| Vapour Pressure | 0.0±2.1 mmHg at 25°C |
| Index of Refraction | 1.700 |